16. Verbondenheid in de
energiehandel
geeft stemkracht!
V O E G V O E G
Vrijhandels Organisatie Vrijhandels Organisatie
voor Elektriciteit en Gas voor Elektriciteit en Gas
www.voeg.nl
info@voeg.nl
postbus 9209, 3007 AE Rotterdam.
17. Programma Conferentie
10.00 uur
10.00 – 10.55 uur
Opening, door dagvoorzitter Judith Richters
Inleiding over leesvaardigheid en het Europees Referentiekader (ERK)
Leesvaardigheid MVT
en het ERK
Prof. Dr. G.J. Westhoff, Onderwijsadviesbureau Leren & Onderwijzen
11.00 - 11.40 uur Presentatie over TaalstERK
Noud van Zuylen en Yvette Goltstein, toetsdeskundigen Cito
11.40 – 12.00 uur Koffiepauze in het restaurant Woensdag 19 mei 2010
12.00 – 13.00 uur Presentatieronde
Het ontwikkelen van leesvaardigheid
13.00 - 13.50 uur Lunch
bij moderne vreemde talen.
14.00 - 16.00 uur Workshopronde, aansluitend evaluatie Voor docenten en sectievoorzitters
moderne vreemde talen.
Praktische informatie
Aanmelden Datum
U kunt zich online aanmelden voor deze conferentie op Woensdag 19 mei 2010
www.cpsacademie.nl. Hier kunt u ook uw voorkeur voor Tijd
presentaties en workshops kenbaar maken. Plaatsing voor een 10.00–16.00 uur
presentatie of workshop gebeurt op volgorde van aanmelding. Locatie
Na aanmelding ontvangt u een schriftelijke bevestiging. CPS, Amersfoort
Annuleren Kosten
Bij schriftelijke annulering tot drie weken voor de start van de € 390,--
bijeenkomst worden administratiekosten (€ 20,-) en Bestemd voor
annuleringskosten (10% van de deelnamekosten) in rekening Docenten en sectievoorzitters moderne vreemde talen
gebracht. Bij schriftelijke annulering minder dan drie weken Meer informatie
voor aanvang van de bijeenkomst wordt 50% van de deelname- Wilt u meer informatie over deze conferentie? Neem dan
kosten in rekening gebracht. Bij schriftelijke annulering minder contact op met CPS Academie, via telefoon [033] 453 43 03 of
dan vijf werkdagen voor aanvang van de bijeenkomst wordt e-mail academie@cps.nl.
100% van de deelnamekosten in rekening gebracht.
Plotterweg 30,
3821 BB Amersfoort
T [033] 453 43 43
F [033] 453 43 53
www.cps.nl
ERK brochure 2010 (2).indd 1 29-01-2010 17:21:16
18. Omslag broch. Calex 2004 26-09-2003 13:49 Pagina 5
Editie nr. 3
LONGER LIFE
CALEX HOLLAND LAMPEN
IN NIEUWE VERPAKKING:
BETER
PRESENTEREN...
BETER
VERKOPEN!
19. EXPERT PRACTICE IN BREAST CANCER
EX PER T PR AC TICE
SM
EXPERT PRACTICE
SM
in breast cancer in lung cancer
SM
17 October 2009
Hotel Radisson Blu
Amsterdam, The Netherlands
18 April 2009
Hotel Sofitel Chain Bridge
This meeting is
accredited by:
Budapest, Hungary
European Society Supported by Genomic Health, GlaxoSmithKline and Pfizer
for Medical Oncology
20. 20 February 2010 | Hotel: The Imperial Riding School Vienna | Vienna, Austria 6 March 2010 | Renaissance Hotel | Amsterdam, the Netherlands
E X PER T PR AC TIC
SM
EXPERT PRACTICE IN BREAST CANCER
EXPERT PRACTICE
SM
EXPERT PRACTICE IN HEMATOLOGY
in breast cancer
SAVE-THE-DATE INVITED FACULTY Faculty
Bojana Pajk*, MD (Moderator)
Michael Gnant*, MD, Austria (chair) Aristoteles Giagounidis, MD, PhD,
Nadia Harbeck*, MD, PhD, Germany Germany (chair)
Robert E. Coleman*, MD, FRCP, United Kingdom Julio Delgado, MD, PhD, Spain
Javier Cortes*, MD, Spain Thierry Facon, MD, France
Norbert Gattermann, MD, PhD, Germany
*To be confirmed
Henk Lokhorst, MD, the Netherlands
Mathias Rummel, MD, Germany
On behalf of Dr Michael Gnant, meeting chairman, Roberto Stasi, MD, PhD, United Kingdom
we are pleased to invite you to the Expert Practice
SM
Delegates will receive: Thorsten Zenz, MD, Germany
in Breast Cancer meeting in Vienna, Austria, on
20 February 2010. Round trip economy air or
train transportation On behalf of Aristoteles Giagounidis, MD, PhD, we
During this case-based meeting, leaders in the field Registration includes:
are pleased to invite you to the Expert Practice SM
will discuss, in an interactive format, clinical issues Welcome reception, dinner,
Hotel accommodation on in Hematology meeting in Amsterdam,
encountered daily by practicing oncologists. coffee break and lunch
19 February 2010 the Netherlands, on 6 March 2010.
SM
Register online at www.primeoncology.org.
SM
For more information, please contact: Registration includes: During this case-based meeting, leaders in the field Register online at www.prIMEoncology.org.
info@primeoncology.org welcome reception, dinner,
discuss with participants, in an interactive format, For more information, please contact:
coffee break and lunch
CME certification will be requested. clinical issues encountered daily by practicing info@prIMEoncology.org
physicians.
CME certification has been applied for with NIV.
Target audience
This educational activity is designed for medical oncologists, radiation oncologists, surgical oncologists, pathologists and other
healthcare providers involved and/or interested in the management of patients with breast cancer.
Agenda
Tentative Agenda 11.45 Case #4—HER2-negative metastatic breast cancer Friday, 5 March 2010
Friday, 19 February 2010 resistant/refractory to anthracyclines and taxanes:
What’s the best approach? 20:00 - 22:00 Welcome reception and buffet dinner
20.00 Welcome reception and buffet dinner Nadia Harbeck, MD, PhD
Saturday, 20 February 2010 12.15 Questions and answers
Saturday, 6 March 2010
09.00 Welcome, introduction and demographics 12.20 Case #5—Endocrine-responsive breast cancer with
Bojana Pajk, MD bone metastases: What are the treatment options? 09:00 Welcome, introduction and demographics 12:10 Case #5—Transfusion dependent myelodys-
Robert E. Coleman, MD, FRCP questions plastic syndrome: Managing iron overload
09.15 Keynote lecture
Unanswered questions in endocrine therapy of breast 12.50 Questions and answers Aristoteles Giagounidis, MD, PhD Norbert Gattermann, MD, PhD
cancer in 2010 12.55 Lunch
Michael Gnant, MD 09:20 Case #1—Chronic lymphocytic leukemia: New 12:45 Lunch
14.00 Clinical opinion poll questions: Challenging the advances in research and treatment
09.40 Case #1—Premenopausal node-negative, endocrine- experts Thorsten Zenz, MD 13:45 Case #6— Relapsed/refractory multiple
responsive early breast cancer Faculty Panel myeloma: Advances in treatment
Nadia Harbeck, MD, PhD 09:55 Case #2—Low-risk myelodysplastic Henk Lokhorst, MD
14.30 Case #6— HER2-positive breast cancer with CNS syndromes: Is there a new standard of care?
10.10 Questions and answers metastases: Opportunities and challenges 14:20 Case #7—Imatinib-resistant chronic
Aristoteles Giagounidis, MD, PhD
10.15 Case #2—Optimizing adjuvant endocrine therapy for Javier Cortes, MD myelogenous leukemia: Optimal use of TKIs
postmenopausal patients 15.00 Questions and answers 10:30 Break Julio Delgado, MD, PhD
Robert E. Coleman, MD, FRCP
15.05 Case #7—Locally-advanced breast cancer: 11:00 Case #3—Emerging options for a patient with 14:55 Case #8—Idiopathic thrombocytopenic
10.45 Questions and answers Neoadjuvant treatment strategies follicular lymphoma purpura: New opportunities for management
10.50 Break Michael Gnant, MD Mathias Rummel, MD Roberto Stasi, MD, PhD
11.10 Case #3—Evaluating the options for triple-negative 15.35 Questions and answers 11:35 Case #4—Initial treatment of an elderly patient 15:30 Concluding Remarks
breast cancer 15:40 Concluding remarks with multiple myeloma
Javier Cortes, MD Michael Gnant, MD Thierry Facon, MD
11.40 Questions and answers
professional independent medical education tel +31 70 30 67 190
professional independent medical education
professional independent medical education tel +31 70 30 67 190
Supported by Pfizer.
Financial support has been provided by Celgene Corporation, GlaxoSmithKline and Novartis Oncology
flyer Amsterdam.indd 1 27-01-2010 11:19:12
21. MIDDELBARE
VEILIGHEIDSKUNDE
Dé MBO-beroepsopleiding op het gebied
van veiligheid en arbeidsomstandigheden
• START IEDERE MAAND
• SKO GECERTIFICEERD
• ONDER AUSPICIËN VAN TNO
KWALITEIT VAN LEVEN
• DIPLOMA VAN
KONINKLIJKE PBNA
Elseviers Opleidingen
Meer dan ‘n papiertje